Mesterolone 25mg (Proviron)

Mesterolone 25mg (Proviron) | NexorinPharma

Mesterolone 25mg is an oral androgen containing 25mg of Mesterolone per tablet. At NexorinPharma, we carry Mesterolone 25mg as part of our oral androgen and ancillary compound inventory for customers in markets where Mesterolone is legally available.

Mesterolone is the active compound in this preparation, marketed under the brand name Proviron. It is a synthetic androgen derived from Dihydrotestosterone with a documented clinical history spanning several decades across multiple international markets. Unlike most oral anabolic steroids, Mesterolone does not use 17-alpha alkylation to achieve oral bioavailability, which consequently produces a significantly lower liver toxicity profile compared to most other oral anabolic steroids discussed in performance communities.

This page covers what Mesterolone is, how it works, and what health and legal considerations apply. It does not constitute medical advice, recommend steroid use, or provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

What Is Mesterolone

Mesterolone is a synthetic androgen and anabolic-androgenic steroid derived from Dihydrotestosterone. Schering developed it and introduced it to several international markets under the brand name Proviron, specifically for the treatment of male hypogonadism, androgen deficiency, and male infertility in several countries.

Structurally, Mesterolone is a modified form of DHT. A methyl group at the first carbon position improves its oral bioavailability and slows its metabolism compared to unmodified DHT. Unlike most oral anabolic steroids, Mesterolone achieves oral activity through this structural pathway rather than 17-alpha alkylation. Most oral anabolic steroids require 17-alpha alkylation to survive first-pass liver metabolism, and that alkylation process is directly associated with liver toxicity. Mesterolone consequently produces a significantly lower hepatotoxicity profile compared to 17-alpha alkylated oral steroids.

How Mesterolone Works

Mesterolone interacts with the body through several distinct pharmacological mechanisms. These mechanisms distinguish it from most other oral androgens and anabolic-androgenic steroids and drive its consistent discussion in both clinical and performance community contexts.

Androgen Receptor Binding

Mesterolone binds to androgen receptors throughout the body. Its androgenic activity drives the primary effects associated with the compound. Furthermore, its anabolic activity is moderate compared to its androgenic profile, which distinguishes it from compounds where anabolic activity significantly exceeds androgenic activity.

SHBG Binding

Sex hormone-binding globulin binds to testosterone and other androgens in circulation, rendering them biologically inactive. Mesterolone binds strongly to SHBG, reducing the proportion of testosterone attached to this protein. As a result, the amount of free testosterone available in the bloodstream increases significantly. This mechanism is consequently one of the most consistently referenced pharmacological characteristics of Mesterolone in performance community discussions.

Mild Aromatase Inhibition

Mesterolone carries mild aromatase inhibiting properties. Aromatase is the enzyme responsible for converting androgens to estrogen, and by partially inhibiting this enzyme, Mesterolone reduces the rate of estrogen conversion. This anti-estrogenic activity is moderate compared to dedicated aromatase inhibitors such as Anastrozole or Exemestane. However, it is a pharmacologically relevant characteristic that distinguishes Mesterolone from most other oral androgens.

No Aromatization

Mesterolone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Consequently, estrogen-related side effects are not part of its direct pharmacological profile. This characteristic distinguishes it from testosterone and many other anabolic-androgenic steroids where estrogenic conversion is a primary side effect consideration.

No Progestogenic Activity

Mesterolone does not show clinically significant affinity for progesterone receptors, which distinguishes it from compounds like Trenbolone and Nandrolone where progestogenic activity is a primary side effect consideration. As a result, Mesterolone carries a cleaner overall hormonal side effect profile compared to progestogenic anabolic steroids.

No Significant HPG Axis Suppression

At standard clinical doses, Mesterolone does not significantly suppress the hypothalamic-pituitary-gonadal axis or natural testosterone production. This distinguishes it from virtually all other anabolic-androgenic steroids discussed in performance communities where HPG axis suppression is a primary health consideration. Consequently, this characteristic drives its discussion as a pharmacologically distinct oral androgen in performance community contexts.

Clinical Background

Mesterolone carries a documented clinical history that provides relevant context for its pharmacological profile and distinguishes it from many anabolic steroids discussed in performance communities.

Male Hypogonadism

Mesterolone has been used clinically in several countries for the treatment of male hypogonadism, a condition characterized by insufficient testosterone production. Its androgenic activity supports testosterone-dependent physiological functions in hypogonadal men. This clinical application consequently gives Mesterolone a documented medical history that most anabolic-androgenic steroids discussed in performance communities do not carry.

Male Infertility

Mesterolone has also been studied and used clinically for male infertility treatment in several countries. Research has examined its effects on sperm production and quality in men with specific fertility-related diagnoses. This clinical application consequently represents a distinct pharmacological use from most anabolic-androgenic steroids, which are associated with suppressing rather than supporting male reproductive function.

Androgen Deficiency

In addition, Mesterolone has been prescribed in several countries for androgen deficiency conditions beyond hypogonadism, including age-related androgen decline. Its clinical use in these contexts provides a medical history that informs its pharmacological profile and further distinguishes it from compounds without approved clinical applications.

About the 25mg Concentration

The 25mg per tablet concentration of Mesterolone is the standard clinical dose format used across all markets where Mesterolone has been prescribed. This concentration aligns with the historical clinical dosing framework for Mesterolone across its approved medical applications in various countries.

Standard Clinical Dose Format

The 25mg tablet is the format in which Mesterolone has been clinically prescribed across markets where it carries regulatory approval. This alignment with historical clinical dosing consequently distinguishes Mesterolone 25mg from higher-dose non-prescription anabolic steroid preparations that exceed standard clinical dose ranges.

Non-Prescription Market Context

Mesterolone 25mg at NexorinPharma is produced for markets where Mesterolone is legally available outside of prescription channels. It does not carry the manufacturing oversight, regulatory scrutiny, or clinical documentation of pharmaceutical grade prescription products. Quality, purity, and concentration accuracy are consequently less verifiable than with regulated products.

Mesterolone Versus Other Ancillary and Oral Androgen Compounds

Versus Anastrozole (Arimidex)

Anastrozole is a dedicated non-steroidal aromatase inhibitor with significantly stronger estrogen suppression than Mesterolone. Unlike Mesterolone, Anastrozole does not carry androgenic activity or SHBG binding properties. Mesterolone, on the other hand, offers moderate aromatase inhibition combined with androgenic activity and SHBG reduction. These are consequently pharmacologically distinct profiles serving different primary functions.

Versus Exemestane (Aromasin)

Exemestane is a steroidal aromatase inhibitor that produces irreversible aromatase enzyme inactivation with significantly stronger estrogen suppression than Mesterolone’s mild inhibitory activity. Furthermore, Exemestane does not carry meaningful SHBG binding or androgenic activity comparable to Mesterolone. The two compounds consequently serve different primary pharmacological roles despite both carrying some aromatase-related activity.

Versus Tamoxifen (Nolvadex)

Tamoxifen is a selective estrogen receptor modulator that blocks estrogen receptors rather than reducing estrogen production. Mesterolone, by contrast, works through aromatase inhibition and SHBG binding rather than receptor blockade. These are fundamentally different mechanisms of estrogen management with different applications and side effect profiles, making them pharmacologically complementary rather than interchangeable.

Versus DHT-Derived Anabolic Steroids

Mesterolone shares its DHT-derived structural origin with compounds like Drostanolone and Stanozolol, and all three are non-aromatizing. Drostanolone and Stanozolol, however, carry significantly higher anabolic activity and more pronounced side effect profiles compared to Mesterolone. Mesterolone’s primary pharmacological role is consequently androgenic and ancillary rather than strongly anabolic.

Versus Oxandrolone (Anavar)

Oxandrolone is a 17-alpha alkylated oral anabolic steroid with mild to moderate liver toxicity. Mesterolone, on the other hand, is non-17-alpha alkylated and carries very low liver toxicity. Both compounds carry relatively mild overall side effect profiles compared to more potent oral anabolic steroids. However, Oxandrolone carries significantly higher anabolic activity than Mesterolone, and Mesterolone’s primary pharmacological role is consequently more ancillary than primarily anabolic.

Side Effects and Health Risks

Mesterolone 25mg carries a side effect profile that differs from most anabolic-androgenic steroids due to its DHT-derived structure and non-17-alpha alkylated formulation. These risks remain real and should not be minimized.

Androgenic Effects

Mesterolone carries androgenic activity that produces side effects in susceptible individuals. These include accelerated hair loss in genetically predisposed individuals, acne on the face and back, and virilization effects in women including voice deepening and changes in body hair distribution. Women should consequently approach any androgenic compound with particular caution given virilization risk.

Cardiovascular Effects

Mesterolone produces adverse changes to lipid profiles, including HDL cholesterol reduction and LDL cholesterol increases associated with androgen use. The severity of these lipid changes is generally considered less pronounced than with more potent anabolic-androgenic steroids. However, cardiovascular monitoring remains relevant for anyone using this compound regardless of its comparatively mild profile.

Liver Considerations

Mesterolone does not carry the hepatotoxicity associated with 17-alpha alkylated oral anabolic steroids, and its non-alkylated structure produces a significantly lower liver stress profile than compounds like Methandrostenolone, Stanozolol, or Oxymetholone. This does not mean liver monitoring is unnecessary. However, the hepatotoxicity risk profile differs fundamentally from alkylated alternatives.

Hormonal Considerations

At standard doses, Mesterolone does not significantly suppress the HPG axis or natural testosterone production. This distinguishes it from virtually all other anabolic-androgenic steroids. However, individual responses vary and hormonal monitoring consequently remains a responsible practice for anyone using androgen compounds.

Psychological Effects

Androgen activity carries documented associations with mood changes and irritability. These effects are generally less pronounced with Mesterolone compared to higher-potency anabolic-androgenic steroids. However, they remain a relevant consideration for anyone using this compound over extended periods.

Legal and Regulatory Status

Mesterolone is not FDA approved in the United States and is not commercially available as a prescription product in the US market. In several European and Asian countries, Mesterolone has historically been available as a prescription medication under the Proviron brand name produced by Bayer. Regulatory status in these markets varies, and you should consequently confirm current availability and legal status in your specific country before purchasing.

The World Anti-Doping Agency bans Mesterolone alongside all major athletic governing bodies. As a result, it appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Mesterolone in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is Mesterolone 25mg Available at NexorinPharma

Yes. NexorinPharma carries Mesterolone 25mg for customers in markets where Mesterolone is legally available. Visit nexorinpharma.com to check current availability and pricing.

What Is the Half-Life of Mesterolone

Mesterolone produces a half-life of approximately 12 hours. As a result, this relatively short half-life is a relevant consideration for maintaining consistent plasma concentrations throughout the day.

Does Mesterolone Aromatize

No. Mesterolone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase, and it also carries mild aromatase inhibiting properties that reduce estrogen conversion from other androgens.

Does Mesterolone Suppress Natural Testosterone Production

At standard clinical doses, Mesterolone does not significantly suppress the hypothalamic-pituitary-gonadal axis or natural testosterone production. This consequently distinguishes it from virtually all other anabolic-androgenic steroids discussed in performance communities.

How Does Mesterolone Differ From Aromatase Inhibitors

Aromatase inhibitors like Anastrozole and Exemestane are dedicated estrogen management compounds with significantly stronger estrogen suppression than Mesterolone. Mesterolone, on the other hand, combines mild aromatase inhibition with androgenic activity and SHBG reduction. These are consequently pharmacologically distinct profiles serving different primary functions.

What Are the Most Serious Health Risks

Androgenic effects including hair loss and acne are the most commonly reported concerns with Mesterolone. In addition, cardiovascular effects on lipid profiles remain relevant, and virilization risk in women is a serious consideration. Liver toxicity is significantly lower than with 17-alpha alkylated oral steroids due to Mesterolone’s non-alkylated structure. Medical supervision is consequently recommended for anyone using this compound.

Is Mesterolone 25mg Legal to Purchase

Legal status varies significantly by country. Mesterolone is not FDA approved in the United States, though it has prescription history in several European and Asian markets. You are consequently responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing Mesterolone 25mg

Mesterolone generates consistent discussion in bodybuilding and performance communities alongside a substantive clinical literature base given its documented prescription history in several countries. This clinical history provides a broader research base for understanding its pharmacological profile than most anabolic-androgenic steroids carry. That research base consequently applies to its pharmacological and risk profile regardless of the specific manufacturer or format.

Non-prescription Mesterolone preparations do not carry the manufacturing oversight of pharmaceutical grade prescription products. Manufacturing standards and quality verification consequently differ between pharmaceutical grade and non-prescription preparations, which is a relevant consideration given Mesterolone’s androgenic effects.

Androgens carry documented cardiovascular, androgenic, and hormonal health considerations that require medical supervision to manage responsibly. Consulting a licensed medical professional is therefore the appropriate starting point for anyone with health concerns related to androgen use.

For customers in markets where Mesterolone is legally available, visit nexorinpharma.com to check current Mesterolone 25mg availability, pricing, and stock levels.